Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior.
By J. González-Maeso, N. Weisstaub, Mingming Zhou, Pokman Chan, L. Ivic, Rosalind L. Ang, A. Lira, M. Bradley-Moore, Yongchao Ge, Qiang Zhou and 2 more. Neuron, 2007
840 citations recorded by the source corpus.
Subfields: Cellular and Molecular Neuroscience, Clinical Psychology, Nutrition and Dietetics
View Paper: https://www.semanticscholar.org/paper/14b085b84b1a27fbbd343f15b615a07d4d2c8d23
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cellular and Molecular Neuroscience
- Robin L. Carhart-Harris
- David J. Nutt
- Dante R. Chialvo
- Murray Shanahan
- Enzo Tagliazucchi
- David E. Nichols
In Clinical Psychology
In Nutrition and Dietetics
Citations in the corpus
- Psychedelics (2016, background): “Furthermore, lisuride is an ergoline with 5-HT2A agonist activity that is not hallucinogenic in humans and also fails to induce the HTR in mice (González-Maeso et al., 2003, 2007).”
- The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs (2014, background): “Despite this however, there has been a resurgence of scientific interest in psychedelics in recent years (Vollenweider et al., 1998; Nichols, 2004; Griffiths et al., 2006, 2008; Moreno et al., 2006; Gonzalez-Maeso et al., 2007; Grob et al., 2011; Carhart-Harris et al., 2012a).”